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Summary We studied the clinical, demographic and survival characteristics of more than 5,000 women
registered with either squamous or adenocarcinoma of the uterine cervix in South Thames Cancer Registry
over the period 1968-81. There were similarities with respect to social class, smoking habit, oestrogen/oral
contraceptive use and time trends in incidence but differences between the two cancers were found with
respect to age distribution, parity, method of detection and survival. Some of the data are of limited value,
having been obtained only from case notes, so the results need some caution in their interpretation. However
the results are broadly consistent with those of studies performed in other countries on smaller samples. A
methodological issue is also raised, viz. the appropriateness of a disease with well-known characteristics as a
comparison group. From our results the likely size of various associations can be judged and used in the
design of future studies to clarify the epidemiology of cervical adenocarcinoma.
Conventional wisdom regards cervical cancer as a disease
associated with sexual activity. The sexual behaviour of both
men and women is incriminated in terms of their respective
numbers of sexual partners (Buckley et al., 1981). The
separate importance of age at first intercourse, however, is in
dispute (Harris et al., 1980; Reeves et al., 1985). There is a
distinct possibility that a virus is transmitted during
intercourse (Spring & Gruber, 1985). These beliefs and the
well known descriptive associations of the disease with age,
age at first pregnancy, marital status, social class and parity,
(Rotkin & King, 1962; Boyd & Doll, 1964; Aitken-Swan &
Baird, 1966; OPCS, 1981) reflect features of the predominant
(squamous) histological type. It is well recognised that
aetiological clues may be uncovered by studies of
epidemiological differences between histological subtypes of
a cancer (Doll et al., 1957, Correa et al., 1973). Nevertheless
some thirty years after Doll's paper this point has needed re-
emphasis (Alderson, 1985). Previous comparisons of cervical
adenocarcinoma and squamous carcinoma have been carried
out in different countries, often in specialist centres and
sometimes with quite small series of patients.
During the period that our cases were registered South
Thames Cancer Registry covered a total female population
of about 3.5 million and routinely collected data on several
of the well described indicators of risk for cervical cancer.
This gave us an opportunity to overcome some of the
limitations of previous studies by comparing characteristics
of squamous and adenocarcinoma subtypes on a single large
set of data.
Subjects and methods
We abstracted details of all 704 histologically confirmed
cases of primary invasive cervical adenocarcinoma and all
4,599 cases of invasive squamous carcinoma registered by the
South Thames Cancer Registry (STCR) during the period
1968-1981 (Figure 1). Tumours are classified in the Registry
according to the International Classification of Diseases for
Oncology (ICD-O) introduced in 1979 (WHO, 1976). Before
1979 tumours were classified according to an extended
version of the ICD edition then in force but these have all
been converted to ICD-O codes by a standard set of criteria
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applied by the Registry. After inspecting the range of ICD-O
codes assigned to primary cervical cancer by STCR, we
defined codes corresponding to adenocarcinoma and
squamous carcinoma together with other categories not used
in the analysis*. Aggregation of closely related codes into a
few broad categories helps prevent bias caused by
inconsistencies in diagnostic and coding practice.
The Cancer Registry routinely abstracts data from hospital
case notes concerning age, date of diagnosis, sex, occupation
(from which social class is derived), extent of disease at
diagnosis, mode of presentation and marital status. Until
1981 number of pregnancies, exposure to known risk factors
and long term use of medicines or drugs were also abstracted
routinely. Linkage of patient records with the NHS Central
Register (NHSCR) ensures that the fact of death is identified
by NHSCR and relayed to the Cancer Registry which allows
calculation of survival despite movement between regions.
Contingency tables comparing the relative frequency of the
above characteristics for the two kinds of cancer were
prepared and odds ratios were calculated where appropriate.
Simultaneous adjustment for several variables was performed
using the computer package GLIM (Baker, 1978), to test
whether the ratio of squamous carcinomas: adenocarcinomas
in a given stratum was a function of those variables.
Survival curves were calculated using the Kaplan-Meier
method, (Kaplan, 1958) and tested for statistical significance
by means of the log-rank test, (Peto et al., 1977) after
stratification for stage and age at diagnosis.
For some dichotomous exposures a substantial proportion
of subjects fell into a 'Not Known' category. Rather than
discard these cases we tested such tables for significance
using a x2 test for trend (Armitage, 1971). Our justification
is that it is reasonable to suppose a 'Not Known' category
to comprise a mixture of 'definitely exposed' and 'definitely
not exposed' persons and thus as a group to have an
intermediate level of exposure.
In addition we calculated time trends in age-standardised
registration ratios for the two kinds of carcinoma (using the
mean of the age specific rates over the whole period as a
separate standard for each disease).
Information on other associated conditions is not recorded
on computer file at STCR. Consequently these data were
abstracted manually from each patients registration form,
*Details available from PBS.
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Figure 1
using all adenocarcinoma cases and a 30% random sample
of squamous carcinomas. Patients were also classified accord-
ing to recorded use of contraceptive pill or other oestrogen-
containing preparations and recorded cigarette use. These
data were originally collected for clinical rather than specific
scientific purposes and the Cancer Registry records do not
distinguish 'unexposed' and 'exposure unknown' categories.
However, given that in women who were exposed taking an
exposure history was unbiased with respect to tumour type,
it is easy to show that an odds ratio obtained by comparing
'definitely exposed' and 'exposure unspecified' categories is a
conservative estimate of the true odds ratio. That is, it is
biased towards unity.
Table II Tumour type by marital status
Marital status %
Tumour type Single Not known Ever married Total
Adenocarcinoma
n=704 7.81 5.26 86.93 100
Squamous carcinoma
n=4599 4.48 5.87 89.65 100
Unadjusted odds ratio of being single if an adenocarcinoma case
(combining 'not known' and 'ever married')= 1.81 (95% CL 1.33-
2.46).
Odds ratio (adjusted for age, social class, number of
pregnancies)= 1.34 (95% CL 0.96-1.87).
Results
The origin of the study sample is depicted in Figure 1.
Adenocarcinomas represented 13% of all histologically
specified invasive cervical carcinomas.
Table I shows that women with adenocarcinomas had a
different age distribution and were 2.7 years older on
average than those with squamous carcinoma. They were
more likely to be single (Table II) and were more likely to be
nulliparous (Table III) - mean number of pregnancies 2.33
and 2.96 respectively. The distributions by social class were
similar. Because age, marital status, parity and social class
were likely to be inter-related, simultaneous adjustment was
performed using GLIM. After this, marital status was no
longer significantly associated with tumour type (adjusted
X2=2.9). The distribution of age (adjusted x2=23.4) and
number of pregnancies (adjusted X2=28.3) by tumour type
remained highly significant (P<0.001). With respect to social
class this multivariate analysis confirmed the similar
distributions of the kinds of tumour, (adjusted X2 =8.33,
Table III Parity by tumour type
Number ofpregnancies %
Diagnosis None Not known I or more Total
Adenocarcinoma
n=704 10.80 33.09 56.11 100
Squamous carcinoma
n=4599 6.33 24.72 68.95 100
Odds ratio of nulliparity if an adenocarcinoma case:
None vs. not known= 1.27
(95% CL 0.95-1.70) _
None vs. 1 or more-2.1 rUndut.
(95% CL 1.60-2.76)
None vs. not known= 1.29
(95% CL 0.90-1.64) L Adjusted for age,
None vs. 1 or more= 1.82 r social class, marital status.
(95% CL 1.36-2.44)
Table I Age distribution of patients with adenocarcinomas and squamous carcinomas
Age group % Mean
age
Diagnosis 0-4 5-14 15-24 25-34 35-44 45-54 55-64 65-74 75+ Total (yrs)
Adenocarcinoma
n=704 0 0.14 0.14 6.25 12.64 20.45 21.31 23.30 15.77 100 58.92
Squamous carcinoma
n=4599 0 0 0.44 7.85 12.74 22.92 27.20 18.35 10.50 100 56.21CERVICAL ADENOCARCINOMA 323
P>0.10), found by the initial univariate analysis. However,
53% of the women were assigned no social class. In this case
it was clearly impossible to assign them an 'intermediate'
value. If the GLIM analysis was restricted to women in
classes I-V, age (X2 =9.42) and parity (X2= 13.17) remained
significantly associated with tumour type at the 1% level.
The association of marital status with tumour type was
further reduced (x2=0.12, P>0.9) while social class showed
a marginally non-significant association (X2=8.0, P=0.064).
However, proportionally fewer adenocarcinoma cases were in
lower social classes (Table IV) and this trend was highly
significant even after adjustment for the other variables
(% =7.1, P =0.008).
Known use of cigarettes or oestrogens/oral contraceptives
was almost equally likely in both groups. While recorded
diagnoses of diabetes and hypertension were both associated
with adenocarcinoma, only the association with hypertension
was statistically significant. These analyses (adjusted for
various combinations of risk factors) are summarised in
Table V.
As far as clinical aspects of the disease are concerned,
women with adenocarcinoma were more likely to present
with advanced disease (Table VI) although this is only
apparent in those who had undergone proper TNM staging.
The route of presentation was then examined, (Table VII)
and it was clear that women with adenocarcinomas were
more likely to present with symptoms rather than through
screening even after adjustment for extent of disease at
presentation (X2 =5.34, P=0.021).
Differences in age and extent of disease did not account
for differences in crude survival between the two kinds of
tumour (Figure 2) because stratification by these variables
still resulted in a highly significant log rank statistic
1 =6.97, P =0.008). The median survival with squamous
carcinoma was about 2 years greater than with
adenocarcinoma.
Although not presented here, during 1968-81 the
standardised registration ratios for both diseases fell, the
decline being slightly greater for squamous carcinoma
although there was no statistically significant difference
between the trends (X2=0.86, P>0.05).
Discussion
Our study demonstrates that similarities exist between
cervical squamous and adenocarcinomas with respect to
social class, known smoking habit, oestrogen/contraceptive
use and time trends, while differences exist with respect to
Table VI Extent of disease at presentation by tumour type
(a)
Cases on which TNM staging was performed
TNM stage (%)
Tumour type 1 2 3 4 Total
Adenocarcinoma
n= 157 21.65 29.30 38.22 10.83 100
Squamous carcinoma 24.80 39.64 28.42 7.14 100
n= 1738
X2 (Trend)=7.46, P<0.007.
(b)
Assessment (%)
Tumour type Early Not known Late Total
Adenocarcinoma
n= 547 3.11 88.66 8.23 100
Squamous carcinoma
n=2861 3.07 89.90 7.03 100
x2 (Trend)=0.62, P>0.05.
Table VII Route of presentation by tumour type
Mode ofpresentation (%)
Tumour type Symptoms Not known Screening Total
Adenocarcinoma
n=704 89.21 7.81 2.98 100
Squamous carcinoma
n=4599 86.43 8.05 5.52 100
A significant negative association exists between presentation
by screening and diagnosis of adenocarcinoma X2 (Trend)=5.34,
(P=0.021) after adjusting for extent of disease.
age distribution, parity, detection, survival and association
with other diseases.
A methodological issue raised by this study concerns the
use of a 'known disease' as a comparison group. This
approach is fundamentally different from the more usual
selection of hospital controls intended to represent the
general population from which cases are drawn. Our method
Table IV Distribution of cases by social class and tumour type
Social class %
Not
Tumour type I II III IV V assigned Total
Adenocarcinoma
n=704 1.14 10.65 23.29 8.81 2.70 53.41 100
Squamous carcinoma
n=4599 0.98 8.57 22.61 10.11 4.87 52.86 100
Proportion of
squamous carcinoma
in each class 0.849 0.840 0.864 0.882 0.922 0.866
Table V Association of suspected risk factors with adenocarcinoma compared with squamous carcinoma
Riskfactor Odds ratio 95% confidence limits Adjustedfor
Cigarette use 0.96 (0.67-1.38) Age, social class
Oestrogen/OC use 1.25 (0.73-2.11) Age, social class, no. of preganancies
Diabetes 1.61 (0.85-3.08) Age, smoking, social class
Hypertension 2.23 (1.12-4.43) Age, smoking, social class324 P.B.S. SILCOCKS et al.
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Figure 2 Survival from cervical carcinoma SE & SW Thames,
1968-81. Difference is significant (chi-square= 13.28, df= 1,
P<0.005), adjusted for age and stage, chi-square =6.97,
P=0.008.
is not ideal but is appr-opr-iate when such controls are not
available. Because of the rarity, of cervical adenocarcinoma
the patients had accrued over- many years, and are a mixture
of dead, newly diagnosed and prevalent cases. This in itself
would raise methodological issues as to appropriate sources
of controls. We chose squamous carcinomas accrued over
the same period because, although recording of known risk
factors for a given site is likely to be biased, this bias should
be minimised if different histological types of the same
cancer are compared. These may not even be distinguished
until later in the registration process. Moreover, risk factors
for squamous carcinoma are well-documented. Such a
'diseased' comparison group whose associations are well
known may be used in two ways: the first is for direct
comparison with the disease of interest and in this respect we
have shown various similarities and differences. The second
is to infer the association that would have been found if
healthy controls had been chosen. For example, women in
our two disease groups did not, overall, differ significantly
with respect to social class although in women of known
class there was a significant gradient in the proportion of
adenocarcinomas with fewer cases being in lower social
classes. We would therefore predict that in comparison with
non-diseased controls, adenocarcinoma cases would show a
weaker social class gradient than is found with cervical
carcinoma in general, i.e., rates in social class V about twice
rather than nearly four times those in class I (OPCS, 1981).
Similar considerations apply to known cigarette smoking and
use of oestrogens/oral contraceptives. Several reports exist of
an association (not always significant) between cigarette
smoking and invasive cervical carcinoma (Wright et al.,
1978; Wigle, 1980; Williams & Horm, 1977; Stellman, 1980;
La Vecchia et al., 1986). If we assume a relative risk of
about 1.75 among smokers for all invasive cervical
carcinoma - and hence for squamous carcinoma - we can
predict the relative risk of adenocarcinoma among smokers
would be about 0.96 x 1.75 = 1.68 (using our estimate of the
association between smoking and tumour type, Table V).
Similarly if we assume a relative risk of 1.11 in oral
contraceptive users (WHO, 1985) we would predict the
relative risk of adenocarcinoma in oestrogen/oral
contraceptive users to be about 1.25 x 1.11 = 1.39. Because
our data only referred to 'known use', misclassification is
likely to have biased our results towards an underestimate.
Nevertheless, such estimates of relative risk might be used to
refine sample size calculations when planning further studies.
Readily available, routinely collected information can thus
be used under certain circumstances even without population
controls, to infer aspects of the epidemiology of a cancer.
Only some 10% of our cases lacked specific histological
typing and our results are broadly similar to those of others
with respect to age, parity, marital status, social class and
survival (Bergsjo, 1963; Korhonen, 1980; Menczer et al.,
1978; Milsom & Friberg, 1983; Tasker & Collins, 1974). Our
finding, that hypertension but not diabetes was associated
with adenocarcinoma rather than squamous carcinoma, is
also consistent with that of Korhonen (1980). On the other
hand while Milsom (1983) found that diabetes rather than
hypertension was associated with adenocarcinoma, both
conditions are associated with obesity and a hormonal basis
for cervical adenocarcinoma remains a possibility as for
endometrial carcinoma (MacMahon, 1974). Because these
odds ratios are obtained from data of limited quality, some
caution is needed in their interpretation. As described earlier
they are conservative estimates. Hence while the 'non-
significant' odds ratios may mask a real association, the true
odds ratio for hypertension is probably greater than that
shown in Table V.
With respect to extent of disease and age at presentation
our results differ from those of Tasker and Collins (1974)
and Bergsjo (1963). However, these studies may be faulted
on the basis of small numbers and a possibly inappropriate
comparison group. We were also unable to confirm
similarities in the pattern of age-specific incidence rates for
intraductal carcinoma of the breast and cervical
adenocarcinoma noted by Henson (1977). The suggestion
(Menczer et al., 1978) that adenocarcinomas are more
susceptible to time trends than squamous carcinomas was
not supported by our data. The age adjusted decline in
invasive adenocarcinoma registrations over 1968-81 was not
significantly different from that in squamous carcinoma
registrations and if anything was rather less, a finding
consistent with greater difficulty in detection of adeno-
carcinoma by screening.
Our series also contains a relatively high proportion of
adenocarcinomas compared with other large series of
invasive cervical carcinoma, (WHO, 1985; Peters et al.,
1986). Many factors could be responsible including age
structure, screening policy and different criteria of
classification but we do not feel that the explanation lies in
contamination of our results by misclassified endometrial
carcinomas. Additional comparisons of cervical and uterine
adenocarcinomas in STCR showed marked differences in age
distribution, marital status, smoking habit and pill use
indicating that the Cancer Registry records successfully
distinguish these conditions.
For the future we suggest that studies should specify
histological type wherever possible. The primary role of
sexual behaviour and other possible risk factors such as
smoking, oral contraceptives (Peters et al., 1986) and
papilloma viruses needs to be assessed as well as that of
Herpes viruses (Menczer et al., 1981; Wilkie et al., 1980).
The quality of histological diagnosis and its changes with
time should also be studied in order to validate conclusions
based on routine data.
We thank Mr Trevor Murrells of the Thames Cancer Registry for
GLIM analyses.
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